Literature DB >> 25097068

Comments on Pérez-Bárcena et al.: a randomized trial of intravenous glutamine supplementation in trauma ICU patients.

Zerrin Ozcelik1, Yucel Gultekin, Seda Banu Akinci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25097068     DOI： 10.1007/s00134-014-3401-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

Review 1.  L-Arginine supplementation in sepsis: beneficial or harmful?

Authors:  Andre C Kalil; Robert L Danner
Journal:  Curr Opin Crit Care       Date:  2006-08       Impact factor: 3.687

2.  Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial.

Authors:  Guido Bertolini; Gaetano Iapichino; Danilo Radrizzani; Rebecca Facchini; Bruno Simini; Paola Bruzzone; Giancarlo Zanforlin; Gianni Tognoni
Journal:  Intensive Care Med       Date:  2003-04-09       Impact factor: 17.440

Review 3.  Specific amino acids in the critically ill patient--exogenous glutamine/arginine: a common denominator?

Authors:  Mechteld A R Vermeulen; Marcel C G van de Poll; Gerdien C Ligthart-Melis; Cornelis H C Dejong; M Petrousjka van den Tol; Petra G Boelens; Paul A M van Leeuwen
Journal:  Crit Care Med       Date:  2007-09       Impact factor: 7.598

4.  A randomized trial of intravenous glutamine supplementation in trauma ICU patients.

Authors:  Jon Pérez-Bárcena; Pedro Marsé; Arturo Zabalegui-Pérez; Esther Corral; Rubén Herrán-Monge; María Gero-Escapa; Mercedes Cervera; Juan Antonio Llompart-Pou; Ignacio Ayestarán; Joan Maria Raurich; Antonio Oliver; Antonio Buño; Abelardo García de Lorenzo; Guiem Frontera
Journal:  Intensive Care Med       Date:  2014-02-21       Impact factor: 17.440
  4 in total
  1 in total

1.  A randomized trial of intravenous glutamine supplementation in trauma ICU patients: response to the comments by Ozcelik et al.

Authors:  Jon Pérez-Bárcena; Abelardo García-de-Lorenzo; Antonio Buño; Juan A Llompart-Pou
Journal:  Intensive Care Med       Date:  2014-08-06       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.